More reads
- I hope the departure of ‘tech-savvy’ Gottlieb won’t undo progress at the FDA. (STAT)
- Biotech shares continue to fall on FDA uncertainty. (CNBC)
- How Roche's $4.8 billion deal for Spark Therapeutics came to be. (Business Insider)
- The nightmarish tale of what happened to a child who wasn’t vaccinated. (STAT)
No hay comentarios:
Publicar un comentario